WO2003051177A2 - Self-scoring method and apparatus for early self-screening of neurological disease - Google Patents

Self-scoring method and apparatus for early self-screening of neurological disease Download PDF

Info

Publication number
WO2003051177A2
WO2003051177A2 PCT/US2002/039800 US0239800W WO03051177A2 WO 2003051177 A2 WO2003051177 A2 WO 2003051177A2 US 0239800 W US0239800 W US 0239800W WO 03051177 A2 WO03051177 A2 WO 03051177A2
Authority
WO
WIPO (PCT)
Prior art keywords
odor
olfactory test
self
test
instruction
Prior art date
Application number
PCT/US2002/039800
Other languages
French (fr)
Other versions
WO2003051177B1 (en
WO2003051177A3 (en
Inventor
William Gartner
Steven Feyrer-Melk
Original Assignee
Fmg Innovations, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmg Innovations, Inc. filed Critical Fmg Innovations, Inc.
Priority to AU2002353133A priority Critical patent/AU2002353133A1/en
Publication of WO2003051177A2 publication Critical patent/WO2003051177A2/en
Publication of WO2003051177A3 publication Critical patent/WO2003051177A3/en
Publication of WO2003051177B1 publication Critical patent/WO2003051177B1/en

Links

Classifications

    • GPHYSICS
    • G09EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09BEDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B3/00Manually or mechanically operated teaching appliances working with questions and answers

Definitions

  • the present invention relates in general to a screening apparatus and method for evaluating a person's olfactory function and, more particularly, to a self- administered and self-scored apparatus and method for self-screening of human diseases and disorders.
  • AD Alzheimer' s .Disease
  • the disease manifests in the degeneration of nerve cells responsible for memory and thought processes.
  • AD has two physiological hallmarks: (1) plagues of largely insoluble plaques of beta-amyloid that develop in areas of the brain responsible for memory and cognitive functions and (2) neurofibrillary tangles, or abnormal collections of twisted threads inside nerve cells.
  • the ultimate cause of the disease remains unknown. Therefore, the diagnosis of AD can only ' be completely confirmed by examination of brain tissue following death to determine whether the levels of plaques and tangles in certain brain regions are characteristic of AD.
  • AD Alzheimer's disease
  • AD olfactory dysfunction
  • Both principal methods are designed for general evaluation of olfactory function.
  • the vial test is reused until the scent diminishes.
  • the vial test requires a health care professional, such as a physician or nurse practitioner, to administer and score the test and then read and interpret the results.
  • the test card method may be self-administered, but a healthcare professional must still score the test and then read and interpret the results.
  • Both the. vial test and test card methods are designed for and dependent ' on the active •involvement of a healthcare professional to screen and interpret the resulting score for indications of neurological disease.
  • FIG. 1 is the front view of the contents of the self-screening olfactory test kit
  • FIG. 2 is the front view of a self-contained, self-administered, and self-scoring olfactory test booklet;
  • FIG. ,3A is the front view of the .inside front cover of the olfactory test booklet and FIG. 3B is the. front view of the outside back cover of the olfactory test booklet;
  • FIG. . is the front view of one odor page of a plurality of substantially uniform odor pages contained in the olfactory test booklet; -
  • FIG. 5 is a three-dimensional view of one odor page of a plurality of uniform odor pages contained in the test booklet;
  • FIGS. 6A, 6B, 6C, and 6D are the front views of the self-scoring and self-screening instructions and mechanism contained in the olfactory test kit; and FIGS. 7A, 7B, 7C, and.7D are flowcharts depicting the self-administered, self-scoring and self- screening olfactory test method.
  • a self-screening olfactory test kit includes a test booklet 12, a sharpened pencil 18, an information booklet 14, and a physician's information card 16.
  • the components are packaged in a sealed paper box 10 with an expiration date placed on the box.
  • FIG. 2 shows a self-contained, self- administered, disposable test booklet 12 for detecting decreased olfactory function as an early sign of neurological disease, in particular, Alzheimer's disease.
  • Test booklet 12 comprises a plurality ot individual strips of paper each measuring 32.0 cm in length by 8.0 cm in width. The strips are folded in half length-wise and are stapled twice in middle of the length, creating pages in booklet form that are. 16.0 cm in len . gth by 8.0 cm in width.
  • Test booklet 12 uses seven strips of paper, creating fourteen pages, each with a front side and a back side, when assembled, including twelve- inside pages, a front cover and a- back cover. The outside of the front cover of test booklet 12 is illustrated in FIG.
  • FIG. 3A shows inside front cover 22 of test booklet 12.
  • Bulleted points labeled "important" are written on inside front cover 22.
  • the bulleted points include: (1) smell loss is the among the first signs of Alzheimer's disease; this screening test measures your ability to smell; (2) do not attempt this screening test if you currently have nasal congestion or long-lasting smell loss due to other known causes; (3) do not scratch the odor strip until you are ready to sniff the odor; (4) poor performance on this screening test does not necessarily mean you have Alzheimer's disease; (5) this screening test works only if the directions are followed precisely as noted; (6) this screening ' test can only be used ' one time .and prior to the expiration date; discard after use; (7) decreased olfactory function (sense of smell) is not the only indicator of Alzheimer's disease;
  • FIG. 3B shows outside back cover 24 of test booklet 12.
  • Bulleted points labeled "test booklet storage and handling" are written on outside back cover 24.
  • the bulleted points include: (1) store this screening test kit in a dry place below 86°F (30°C) ; do not refrigerate; (2) do not scratch microencapsulated odor strips until ready to use; (3) sniff microencapsulated odor strips immediately after scratching; (4) do not contact microencapsulated odor strips with any liquid; (5) do not re-use microencapsulated odor strips; discard test after use; (6) this screening test can only be used one time and prior to the expiration date.
  • FIG. 4 shows one odor page 28 of a plurality of substantially uniform pages.
  • Test booklet 12 is comprised of twelve substantially uniform pages.
  • the back of odor page 28 is blank, except back side of last odor page 44 which is shown in FIG. 6B.
  • Each odor page 28 contains the same instructions 30 on the left side of the front of odor page 28 labeled "easy step-by-step instructions.” Instructions 30 comprise illustrated step-by-step directions for self-administration of the test.
  • the first instruction is numbered as one and says "use pencil provided, scratch odor strip in a ZIG-ZAG.”
  • Immediately under the instruction is an illustration of odor strip 36 with a zig-zag line crossing horizontally from the left to the right, back to the left and then again to the right.
  • the next instruction is numbered as two and says "place odor strip directly under, both nostrils and sniff.”
  • To the right of instruction number two is an illustration of odor page 28 of test booklet 12 with an arrow pointing from odor strip 36 to the right to an illustration of a front view of a human head, the arrow terminating below the nostrils.
  • the next instruction is numbered three and says “circle the best answer. You must circle one answer.”
  • Immediately under the instruction is the phrase “your choice” with a circle around it.
  • the ' next eleven odor pages 28 contain identical instructions 30, in the same orientation.
  • the right side of the front of odor page 28 has an odor number 32, labeled as "ODOR #,” written in the upper right corner.
  • the first odor page is labeled “Odor #1,” and each of the next eleven odor pages 28 are labeled .with an increasing sequential odor number 32, e.g., "Odor #2,” “Odor #3,” etc.
  • Below odor number 32 the phrase “this odor smells most like:” is written. Immediately underneath that phrase, in parentheses, is written "circle one.”
  • odor labels 34 are listed above the odor-containing source, odor strip 36. Odor labels 34 are displayed in a right-justified, vertical list with one odor label per horizontal line. Four possible " odor labels 34 are listed as possible identities for each odor strip 36 where one odor label ' is the correct identity for each odor strip 36. Using four possible odor labels 34 for each odor strip 36 decreases the expected score on the basis of random responding, to three, or twenty-five percent. Therefore, this increases the probability that a low score, between four and eight, is due to olfactory dysfunction and not a false-positive result due to malingering.
  • the sets of odor labels 34 as possible identities for each odor strip 36 are: (1) fruit, cinnamon, woody and coconut, where cinnamon is the correct identity; (2) turpentine, soap, dog and black pepper, where turpentine is the correct identity; (3) motor oil, garlic, rose and lemon, where lemon is the correct identity; (4) apple, grass, smoke and grape, where smoke is the correct identity; (5) lemon, strawberry, chocolate and black pepper, where chocolate is the correct identity; (6) mint, rose, lime and fruit where rose is the correct identity; (7) watermelon, peanut, rose ' and paint thinner, where paint thinner is the correct identity; (8) banana, garlic, cherry and motor oil, where banana is the correct identity; (9) smoke, whiskey, pineapple and onion, where pineapple is the correct identity; (10) rose, lemon, apple and gasoline, where gasoline is the correct identity; (11) soap, black pepper, chocolate and peanut, where soap is the correct identity; (12) chocolate, banana, onion and fruit, where onion is the correct identity.
  • Odor labels 34 listed above are used because studies indicate that particular scents corresponding to odor labels 34 are universally familiar and recognizable by persons from a variety of cultures.
  • the terms used as odor labels 34 are also selected to maximize recognition across a diverse population. For example, the term “woody” is used instead of “pine” because “woody” is a culture-free response as opposed to “pine.”
  • Using cross- culturally recognized odor labels 34 reduces examinee confusion resulting from unfamiliarity ' with the scent corresponding to each odor label. " -mererore, raise- positive test results detecting examinee confusion due to , cultural unfamiliarity with odor labels 34, rather than actual olfactory dysfunction, are reduced.
  • odor labels 34 are grouped in a particular manner described above because the scents corresponding to odor labels 34 on each odor page 28 are different and distinct from one another. Providing groupings of odor labels 34 with readily distinguishable scents decreases examinee confusion not due to actual olfactory dysfunction. Gross, rather than small, differences in scent between odor labels 34, decreases the likelihood of false-positive test results due to a confusion between scents. Therefore, the particular selection and grouping of odor labels 34 decreases the occurrence of false-positive test results and increases the reliability of the olfactory test as an indicator of olfactory dysfunction. [0017] A rectangle with rounded corners, the same dimensions as odor strip 36, 4.0 cm.
  • odor strip 36 in length by 1.25 cm in width, illustrating where odor strip 36 should be attached, is printed on the right bottom corner of odor page 28.
  • the printed rectangle allows for consistent uniform attachment of odor strip 36 to odor page 28 during assembly of test booklet 12.
  • Each odor page 28 has a different odor strip 36 attached in the printed rectangle to odor page 28 via adhesive.
  • FIG. 5 is a three-dimensional view of odor page 28.
  • Odor strip 36 is an odor-containing source. Odor strip 36 contains a plurality of rupturable microcapsules . A distinct scent is located within the microcapsules which is emitted when the microcapsules rupture or burst, as a result of scratching the surface of odor strip 36 with pencil 18. Other objects can be used to scratch the surface of odor strip J6 so as to accomplish rupture. As the microcapsules are ruptured, a burst of fragrance of the distinct scent contained within the .microcapsules is given off. Pencil 1.8 is provided in the te.st kit for the examinee to use to scratch the surface of odor strip 36 and rupture the microcapsules.
  • Odor strip 36 is a rectangular strip of paper with rounded corners measuring 4.0 cm in length by 1.25 cm in width. Each odor page 28 contains one odor strip 36 each containing one of the following odors: cinnamon, turpentine, lemon, smoke, chocolate, rose, paint thinner, banana, pineapple, gasoline, soap, and onion. A particular odor strip 36 is chosen from the grouping of odor labels 34 to provide a diverse, cross-cultural olfactory test. Odor- strips 36 comprise six food-related odor strips and six nonfood-related odor strips. Odor -strips 36 are also chosen based on commercial availability. [0020] Each odor strip 36 has a unique distinguishing visual feature. Each odor strip 36 is a different color.
  • each odor strip 36 (1) for cinnamon, brown; (2) for turpentine, light yellow; (3) for lemon, light green; (4) for smoke, peach; (5) for chocolate, light pink; (6) for rose, white; (7) for paint thinner, gray; (8) for banana, dark pink; (9) for pineapple, orange; (10) for gasoline, green; (11) for soap, dark yellow; and (12) for onion, blue.
  • Different colored odor strips are used for post-assembly verification and quality assurance.
  • each odor page 28 can ' be checked to ensure that the correct odor strip 36 was attached to its respective corresponding odor number 32.
  • Other colors can be used to distinguish odor strips 36.
  • other coding schemes using distinguishing visual features can be employed.
  • FIG. 6A is inside back cover 38 of- test booklet 12 containing answer key 40.
  • Answer key cover 43 is paper, 16.0 cm in length by 7.0 cm in width attached 1.0 cm below the top of inside back cover 38 via adhesive. The paper is dense to prevent the text of answer key 40 from being visible through answer key cover 43.
  • the bottom of inside back cover 38 and bottom of- answer key cover 43 are attached with a breakable seal. Answer key cover 43 hides answer key 40 from view until the seal is .broken and answer key cover 43 is lifted to view answer key 40.
  • Inside back cover 38 is labeled "answer key.” Underneath the label is written "important: .
  • the -label and text are located in the top 1.0 cm of inside back cover 38, so as to be visible with answer key cover 43 attached.
  • FIG. 6B illustrates top half 46 of back side of last odor page 44.
  • Top half 46 of FIG. 6B is labeled "scoring the test” and gives instructions for self- scoring the olfactory test from answer key 40.
  • Self- scoring reveals the number of odor-containing sources examinee incorrectly identified. The total number of incorrect identifications is used in self-screening a positive or negative result of the olfactory test.
  • the step-by-step instructions for self-scoring are: (1) after. sniffing all 12- odor strips ' 36 and circling one answer per page,, remove answer key cover 43 and look at answer key 40, FIG.
  • bottom half 48 also illustrates bottom half 48 of back side of last odor page 44.
  • Bottom half 48 provides instructions for self-screening to determine a positive or negative result of the olfactory test based on the total number of incorrect answers self-scored from answer key 40.
  • Bottom half 48 is labeled "reading the results.” Below the label are the self-screening instructions:
  • FIG. 6C is information booklet 14.
  • Information booklet 14 comprises one blue sheet- of paper 28.0 cm in length by 16.75 cm in width. The paper is folded in half lengthwise to create a four page booklet that is 14.0 cm in length by 16.75 cm in width.
  • information booklet 14 is titled "Information Booklet” and subtitled "Early Alert Home Screening Test for Alzheimer's Disease.”
  • the first page contains an initial instruction under the subtitle to "please read all of the instructions completely before performing the screening test. The directions will help .you correctly perform the test and read the results.”
  • a telephone help line number and a website address are also listed.
  • the text states that "smell loss is among the first signs of Alzheimer's disease (AD).
  • the Early Alert Alzheimer's Home Screening Test is a smell test that allows an individual to determine if a loss of olfactory function (the ability to smell) is present. Although not all older persons with smell loss have AD, such loss, alone or in combination with memory problems and/or certain genetic markers, is among the best predictors or indicators of AD. Early Alert has been designed to assist in early detection of possible AD by determining if you have a degraded sense of smell.- Failing the test does not .necessarily mean you have AD. If you fail the screening test you should consult your physician.
  • test limitations subsequently follow.' The statements are: (1) the Early Alert screening test works only if the directions are followed precisely as noted; (2) the Early Alert screening test kit can only be used one time and prior to the expiration date; (3) decreased olfactory function (sense of smell) is not the only indicator of potential AD; and (4) decreased olfactory function ⁇ (sense of smell) can be found in older individuals without AD. Finally, at the bottom of the first page is text labeled "test validity and reliability.” The text states that "this test is the most widely employed means of quantitatively assessing the sense of smell. Numerous published scientific and medical studies have employed this exact format and a number have found smell loss to be among the first, if no the first signs of AD.
  • the second page located " on the reverse of the first page, is titled “directions” and subtitled “how to. take the test.”
  • the second page is divided into two sections.
  • the first section is labeled "cautions,” and comprises bulleted statements. The statements are: (1) do not attempt the screening test- if you . currently have nasal congestion or long-lasting smell loss due to other known causes; (2) do not scratch the odor strip until you are ready to sniff the odor; (3) poor performance on the screening test does hot necessarily mean you have
  • Alzheimer's disease (4) read all of the contents of this information booklet before you begin the screening test; (5) do not turn to the answer key or look at the answer key before completing the test.
  • the second section is labeled "directions" and contains sequentially numbered instructions and illustrations. Instruction number one is "open the screening test booklet to the first page, which is titled Odor #1.” The next two instructions are the same as the first two instruction's 30 on odor page 28, with the same illustrations .
  • Instruction number four is "look at the choices provided on the page located above the odor strip. If you are not sure or no smell is present, pick the one that seems closest. Circle the best answer. You must circle one answer.” Centered under instruction number four is the phrase “example of answer choice.” Centered below the phrase is a vertical list, one choice per horizontal line, of four odor labels: fruit, cinnamon, coconut, and woody. Fruit is circled. Instruction number five is “turn the page of the test booklet to the second page which contains Odor #2. Repeat Step 2 through Step 4 above.” Instruction number six is “continue this process until all 12 odor strips have been sniffed and an answer has been circled for each odor.” [0032] The third page labeled "directions" comprises three sections.
  • the first section is labeled "how to score the test.”
  • the text in the first section is the same as top half 46 of back side of last odor page 44. With the text is an illustration of how to self-score each answer.
  • the example shows "Odor #1, oody” with a line through, i.e. "Odor #1 Woody-.--” Additionally, an illustration of blank box 42, 1.75 cm in length by 0.4 cm in width, is given to the right of the phrase "total number incorrect.”
  • the second section is labeled "reading the results.”
  • the text in the second section is the same text found in bottom half 48 of back side of last odor page 44.
  • the third section is .labeled "frequently asked questions.” Seven questions, each question labeled on the left with a "Q, " are paired with an answer, labeled on he left with an "A.” The seven questions and paired answers are: (1) Why do I want to take a home screening test for Alzheimer's? Early diagnosis is very important. Increasing you awareness of possible Alzheimer' s disease can help you receive further testing which may lead to potential diagnosis.
  • the fourth page is untitled and contains three sections.
  • the first section is labeled "Alzheimer's Disease - more information'-.”
  • the first section provides general information on Alzheimer's Disease and lists websites with more information on Alzheimer's Disease.
  • the second section is labeled "signs and symptoms.”
  • the section begins with "the following information is- taken from a widely distributed list of warning signs for Alzheimer's disease.”
  • the statement is then followed eight items arranged in a two column vertical unnumbered list, with four items in each column.
  • the items in the first, left column are: (1) misplacing things; (2) word finding problems; (3) poor or decreased judgment; and (4) recent memory loss.
  • the items in the second, right column are: (1) difficulty performing familiar tasks; (2) disorientation to time and place; (3) loss of interest; and (4) changes in mood or behavior.
  • the third section is labeled "medical and scientific references.”
  • the third section lists journal articles on Alzheimer's Disease and olfactory dysfunction.
  • FIG. 6D is physician's information card 16 labeled "physician's information.”
  • Physician's information card 16 comprises one sheet of paper, 17.0 cm in length by 8.5 cm in width.
  • Physician's information card 16 has text printed on both the front side of the card and the back side of the card.
  • Immediately below the title on the front side of .th physician's information card are the statements: "we ⁇ ' strongly recommend that you bring this card with ' you when conferring with your physician. We also suggest that you bring the screening. test and information booklet.”
  • Physician information card 16 is then formatted as a letter to the physician, beginning, "dear physician.” The text of the letter explains the olfactory test methodology and indications of a positive .result.
  • FIG. 7A is a flowchart of the preparation for self-administration the olfactory test.
  • An examinee opens in step 60 the sealed paper box 10 and removes in step 60 the contents: test booklet 12, information booklet 14, physician information card 16, and pencil 18.
  • step 62 examinee reads information booklet 14.
  • step 64 if examinee has long lasting smell loss due to other known causes, examinee is instructed in step 76 not to take the olfactory test. If not, but in step 66 examinee currently has nasal congestion, examinee is instructed in step 78 not to take the olfactory test and, in step 86, to store the test until nasal congestion clears.
  • step 80 through 84 examinee stores the test in a dry place at a temperature below 30°C (86°F), but does not refrigerate the test. If examinee fails to comply with the storage instructions, then step 76 instructs examinee not to take the olfactory test and to discard the test.
  • step 76 instructs examinee not to take the olfactory test and to discard the test. If not, then in step 74, examinee may begin the olfactory test.
  • FIG. 7B is a flowchart of the ' self- administration method of the olfactory test.
  • examinee breaks the seal of test booklet 12 and in step 90 opens test booklet 12 to inside front cover 22.
  • step 92 examinee reads the points labeled "important" on inside front cover 22. If examinee has looked at answer key 40 in step 94, then in step 96, examinee is instructed not to take the olfactory test.
  • step -94 if examinee has not looked at answer key 40, then in step 98, examinee looks at first odor page 28.
  • step 100 examinee uses the sharp end of pencil 18 to scratch odor strip 36 several times in a .
  • step 102 examinee places odor strip 36 directly under both nostrils and in step 104, sniffs odor strip 36.
  • step 106 examinee looks at odor labels 34 and in step 108, uses pencil 18 to circle the odor label that odor strip 36 smells most like.
  • step 110 if odor page 28 is not odor #12, then in step 112, examinee turns to the next odor page 28 and repeats steps 100 through 110. When in step 110 the odor number is twelve, then examinee begins to score the test in step 114.
  • FIG. 7C is a flowchart of the olfactory test's self-scoring method to determine a number of incorrect answers that indicate a positive result.
  • step 114 after examinee circles an odor label for Odor #12, examinee turns in step 116 to back side of last page 44, and in .step 118 reads the "scoring the -test" section on top half 46.
  • step 120 examinee looks at- answer key 40 on inside back cover 38.
  • step 122 examinee looks at the answer for odor #1.
  • step 124 examinee then looks at the circled odor label for odor #1.
  • step 126 if the circled label for odor #1 matches the answer for odor #1 in answer key 40, examinee looks at .
  • step 126 the answer for odor #1 does not match the circled odor label for odor #1, then examinee, in step 128, uses pencil 18 to draw a line through the answer in answer key 40, and then repeats steps 124 through 132.
  • step 132 the odor number is twelve, examinee counts in step 134 the answers in answer key 40 with a line through (the incorrect answers) .
  • step 136 examinee records the total number of incorrect answers in blank box 42 provided next to the phrase "total incorrect number.”
  • step 138 examinee then self-screens the score.
  • FIG. 7D is a flowchart of the olfactory test's self-screening method to determine a positive or negative result from the total number of incorrect answers self- scored from answer key 40.
  • step 140 examinee reads bottom half 48 of back side of last odor page 44,
  • examinee is instructed to consult a physician in step 150. If the examinee needs to consult a physician in step 150, then examinee is further instructed in step . 152 to take physician's information ' card 16 to the physician.
  • step 142 if examinee's total incorrect number is less than four, then examinee is instructed in step 144 to read the section in information booklet 14 labeled "signs and symptoms.”
  • step 146 if examinee is experiencing any of the listed signs or symptoms of Alzheimer's Disease, examinee is instructed in step 150 to consult a physician. If the examinee needs to consult a physician in step 150, then examinee i ' s further instructed in step 152 to take physician's information card 16 to the physician. If examinee's total number -incorrect is less than four ' in step 142 and examinee is not experiencing any listed signs or symptoms of Alzheimer's Disease in step 146, examinee in step 148 needs to take no further action.
  • the self-screening olfactory test kit eliminates the need for healthcare professional involvement for initial screening of neurological disease.
  • the olfactory test kit requires only a small time commitment since an individual can self-administer and self-score the olfactory test in about, five minutes. Additionally, the r cost of the olfactory test kit for individual desiring initial screening of neurological disease is minimal compared with an office visit to a healthcare professional.
  • the olfactory test kit provides individuals with a simple self-screening method to determine a positive result of the olfactory test upon incorrectly identifying one-third or more of the total number of odor-containing areas.
  • a positive result of the . olfactory test is an indication of olfactory dysfunction which is not a diagnosis of neurological disease rather an indication that an individual should take further action regarding possible neurological disease, such as consulting a physician.
  • Individuals not only self- administer the olfactory test in a private, in-home setting, but also self-score the olfactory test to determine themselves if the results indicate that further action is required.
  • the olfactory test kit is a quick, inexpensive, private, self-screening, diagnostic tool that does not incur anxiety associated with healthcare professional involvement. As a result, the olfactory test kit will avail more individuals of the benefits of early screening of possible neurological disease. ' [0049] Although the present invention has been described with respect to preferred embodiments, any person skilled in the art will recognize that changes may be that changes be made in form and detail, and equivalents may be substituted for -elements of the invention without departing from the spirit and scope of the invention'. Many modifications may be made to adapt to a particular situation or material to the teaching of .the invention without departing from the essential scope of the invention. Therefore, it is intended that the invention not be limited to the particular embodiments disclosed for carrying out this invention, but that the invention will include all embodiments falling within the scope of the appended claims.

Abstract

A self-administered and self-scoring test kit and method for early self-screening of neurological disease, by detection of diminished olfactory function. The test kit is comprised of a plurality of pages; attached to each page (28) via adhesive is a microencapsulated strip (36) that, when scratched, releases a different, distinct odor. The test kit has instructions that provide for self-administration (33) and self-scoring (46) of the test, and identification of a threshold score (48) as a self-screening method for possible neurological disease and need to consult a physician.

Description

SELF-SCORING METHOD AND APPARATUS FOR EARLY SELF- SCREENING OF NEUROLOGICAL DISEASE
FIELD OF THE INVENTION
[0001] The present invention relates in general to a screening apparatus and method for evaluating a person's olfactory function and, more particularly, to a self- administered and self-scored apparatus and method for self-screening of human diseases and disorders.
BACKGROUND OF THE INVENTION [0002] Alzheimer' s .Disease (AD) is a progressive, degenerative disease that affects the brain resulting in impaired thinking, uncharacteristic behavior and memory loss. The disease manifests in the degeneration of nerve cells responsible for memory and thought processes. AD has two physiological hallmarks: (1) plagues of largely insoluble plaques of beta-amyloid that develop in areas of the brain responsible for memory and cognitive functions and (2) neurofibrillary tangles, or abnormal collections of twisted threads inside nerve cells. The ultimate cause of the disease remains unknown. Therefore, the diagnosis of AD can only' be completely confirmed by examination of brain tissue following death to determine whether the levels of plaques and tangles in certain brain regions are characteristic of AD. Because there is no cure for AD, early diagnosis of AD is critical for patients in giving them the benefit of drug therapies that may alleviate more moderate, early symptoms of AD and enhance their quality of life. Early diagnosis allows for the most effective treatment, medical and social management, and personal and family planning. [0003] In diagnosing AD, physicians employ a battery of diagnostic tests, including a complete medical history, physical exam, blood and urine analysis, and memory and psychiatric assessment, such as the Wechsler Memory Test and the Mini Mental State Examination. Assessment of olfactory function is employed in diagnosing AD. Patients with various neurological disorders, including AD, Parkinson'.s Disease, Huntington' s Disease, Down's Syndrome and schizophrenia, often suffer an impaired sense of smell. The patients exhibit signs. of olfactory dysfunction even before the patients manifes't other symptoms of AD. Differential olfactory performance recognized between healthy and affected patients, along with lack of awareness of olfactory deficit, provide a mechanism for early screening and diagnosis of AD. Studies suggest that assessment of olfactory function is more reliable than standard cognitive capacity tests, and that diminished sense of smell, along with other factors, such as memory loss and genetic factors, provides the best indicator of AD.
[0004] Two principal methods are used to clinically evaluate olfactory function. In one method, vials of scented liquids, each with a distinct scent, are used to assess the examinee's sense of smell. A complete test kit requires several vials of liquid. The second method involves test cards with distinct odor strips affixed to each card. Odor is released when scented microcapsules within each strip are ruptured. Rupture is accomplished either by scratching the surface of the strip or by removal of an adhesive securing the strip to the card. Examples of such tests include the 40-item University of Pennsylvania Smell Indentification Test (UPSIT) and the 12-item Cross-Cultural Smell Identification Test (CC- SIT) .
[0005] Both principal methods are designed for general evaluation of olfactory function. The vial test is reused until the scent diminishes. The vial test requires a health care professional, such as a physician or nurse practitioner, to administer and score the test and then read and interpret the results. The test card method may be self-administered, but a healthcare professional must still score the test and then read and interpret the results. Both the. vial test and test card methods are designed for and dependent ' on the active •involvement of a healthcare professional to screen and interpret the resulting score for indications of neurological disease.
[0006] In the prior art tests, the required involvement of a healthcare professional has a number of disadvantages. The involvement of a healthcare professional significantly increases the cost to an individual desiring screening. Additionally, visits to a healthcare professional require a considerable time commitment. Furthermore, individuals may perceive mandatory professional involvement as an invasion of privacy. Finally, anxiety and trepidation, are often associated with visiting a professional to assess neurological disease. Individually or in combination, these factors can easily dissuade a possible sufferer of neurological disease from early screening and diagnosis. As a result, many individuals will deny themselves the benefit of a useful diagnostic tool. BRIEF DESCRIPTION OF THE DRAWINGS [0007] FIG. 1 is the front view of the contents of the self-screening olfactory test kit;
FIG. 2 is the front view of a self-contained, self-administered, and self-scoring olfactory test booklet;
FIG. ,3A is the front view of the .inside front cover of the olfactory test booklet and FIG. 3B is the. front view of the outside back cover of the olfactory test booklet;
FIG. . is the front view of one odor page of a plurality of substantially uniform odor pages contained in the olfactory test booklet; -
FIG. 5 is a three-dimensional view of one odor page of a plurality of uniform odor pages contained in the test booklet;
FIGS. 6A, 6B, 6C, and 6D are the front views of the self-scoring and self-screening instructions and mechanism contained in the olfactory test kit; and FIGS. 7A, 7B, 7C, and.7D are flowcharts depicting the self-administered, self-scoring and self- screening olfactory test method.
DETAILED DESCRIPTION OF THE DRAWINGS [0008] As shown in FIG. 1, a self-screening olfactory test kit includes a test booklet 12, a sharpened pencil 18, an information booklet 14, and a physician's information card 16. The components are packaged in a sealed paper box 10 with an expiration date placed on the box.
[0009] FIG. 2 shows a self-contained, self- administered, disposable test booklet 12 for detecting decreased olfactory function as an early sign of neurological disease, in particular, Alzheimer's disease. Test booklet 12 comprises a plurality ot individual strips of paper each measuring 32.0 cm in length by 8.0 cm in width. The strips are folded in half length-wise and are stapled twice in middle of the length, creating pages in booklet form that are. 16.0 cm in len.gth by 8.0 cm in width. Test booklet 12 uses seven strips of paper, creating fourteen pages, each with a front side and a back side, when assembled, including twelve- inside pages, a front cover and a- back cover. The outside of the front cover of test booklet 12 is illustrated in FIG. 2, including a label "Alzheimer's Home Screening Test" written across the center and the text "Important: Information booklet provided. Read the entire booklet prior to beginning this screening test. Follow the instructions carefully." written in lower right corner 20. Inside front cover 22 is illustrated in FIG. 3A. Outside back cover 24 is illustrated in FIG. 3B. Inside back cover 38 is answer key 40 illustrated in FIG. 6A. Odor pages 28 are substantially uniform, each oriented to a different odor-containing source, odor strip 36, and laid out as shown in FIG. 4. The first eleven odor pages 28 are blank on the back side. Back side of last odor page 44 is illustrated in FIG. 6B. [0010] FIG. 3A shows inside front cover 22 of test booklet 12. Bulleted points labeled "important" are written on inside front cover 22. The bulleted points include: (1) smell loss is the among the first signs of Alzheimer's disease; this screening test measures your ability to smell; (2) do not attempt this screening test if you currently have nasal congestion or long-lasting smell loss due to other known causes; (3) do not scratch the odor strip until you are ready to sniff the odor; (4) poor performance on this screening test does not necessarily mean you have Alzheimer's disease; (5) this screening test works only if the directions are followed precisely as noted; (6) this screening ' test can only be used' one time .and prior to the expiration date; discard after use; (7) decreased olfactory function (sense of smell) is not the only indicator of Alzheimer's disease;
(8) decreased olfactory function (sense of smell) can be found in older individuals without Alzheimer's disease;
(9) do not turn to the answer key or look at the answer key until you have completed the test. [0011] FIG. 3B shows outside back cover 24 of test booklet 12. Bulleted points labeled "test booklet storage and handling" are written on outside back cover 24. The bulleted points include: (1) store this screening test kit in a dry place below 86°F (30°C) ; do not refrigerate; (2) do not scratch microencapsulated odor strips until ready to use; (3) sniff microencapsulated odor strips immediately after scratching; (4) do not contact microencapsulated odor strips with any liquid; (5) do not re-use microencapsulated odor strips; discard test after use; (6) this screening test can only be used one time and prior to the expiration date. Phrase 26 "single use only - discard after use" is written below the bullet points. [0012] FIG. 4 shows one odor page 28 of a plurality of substantially uniform pages. Test booklet 12 is comprised of twelve substantially uniform pages. The back of odor page 28 is blank, except back side of last odor page 44 which is shown in FIG. 6B. Each odor page 28 contains the same instructions 30 on the left side of the front of odor page 28 labeled "easy step-by-step instructions." Instructions 30 comprise illustrated step-by-step directions for self-administration of the test. The first instruction is numbered as one and says "use pencil provided, scratch odor strip in a ZIG-ZAG." Immediately under the instruction is an illustration of odor strip 36 with a zig-zag line crossing horizontally from the left to the right, back to the left and then again to the right. The next instruction is numbered as two and says "place odor strip directly under, both nostrils and sniff." To the right of instruction number two is an illustration of odor page 28 of test booklet 12 with an arrow pointing from odor strip 36 to the right to an illustration of a front view of a human head, the arrow terminating below the nostrils. The next instruction is numbered three and says "circle the best answer. You must circle one answer." Immediately under the instruction is the phrase "your choice" with a circle around it. The next instruction, numbered four, says "turn the page," and has no illustration. The' next eleven odor pages 28 contain identical instructions 30, in the same orientation.
[0013] The right side of the front of odor page 28 has an odor number 32, labeled as "ODOR #," written in the upper right corner. The first odor page is labeled "Odor #1," and each of the next eleven odor pages 28 are labeled .with an increasing sequential odor number 32, e.g., "Odor #2," "Odor #3," etc. Below odor number 32, the phrase "this odor smells most like:" is written. Immediately underneath that phrase, in parentheses, is written "circle one."
[0014] Below the phrases, odor labels 34 are listed above the odor-containing source, odor strip 36. Odor labels 34 are displayed in a right-justified, vertical list with one odor label per horizontal line. Four possible" odor labels 34 are listed as possible identities for each odor strip 36 where one odor label' is the correct identity for each odor strip 36. Using four possible odor labels 34 for each odor strip 36 decreases the expected score on the basis of random responding, to three, or twenty-five percent. Therefore, this increases the probability that a low score, between four and eight, is due to olfactory dysfunction and not a false-positive result due to malingering. The sets of odor labels 34 as possible identities for each odor strip 36 are: (1) fruit, cinnamon, woody and coconut, where cinnamon is the correct identity; (2) turpentine, soap, dog and black pepper, where turpentine is the correct identity; (3) motor oil, garlic, rose and lemon, where lemon is the correct identity; (4) apple, grass, smoke and grape, where smoke is the correct identity; (5) lemon, strawberry, chocolate and black pepper, where chocolate is the correct identity; (6) mint, rose, lime and fruit where rose is the correct identity; (7) watermelon, peanut, rose' and paint thinner, where paint thinner is the correct identity; (8) banana, garlic, cherry and motor oil, where banana is the correct identity; (9) smoke, whiskey, pineapple and onion, where pineapple is the correct identity; (10) rose, lemon, apple and gasoline, where gasoline is the correct identity; (11) soap, black pepper, chocolate and peanut, where soap is the correct identity; (12) chocolate, banana, onion and fruit, where onion is the correct identity. [0015] Odor labels 34 listed above are used because studies indicate that particular scents corresponding to odor labels 34 are universally familiar and recognizable by persons from a variety of cultures. The terms used as odor labels 34 are also selected to maximize recognition across a diverse population. For example, the term "woody" is used instead of "pine" because "woody" is a culture-free response as opposed to "pine." Using cross- culturally recognized odor labels 34 reduces examinee confusion resulting from unfamiliarity 'with the scent corresponding to each odor label. " -mererore, raise- positive test results detecting examinee confusion due to, cultural unfamiliarity with odor labels 34, rather than actual olfactory dysfunction, are reduced. [0016] Additionally,, odor labels 34 are grouped in a particular manner described above because the scents corresponding to odor labels 34 on each odor page 28 are different and distinct from one another. Providing groupings of odor labels 34 with readily distinguishable scents decreases examinee confusion not due to actual olfactory dysfunction. Gross, rather than small, differences in scent between odor labels 34, decreases the likelihood of false-positive test results due to a confusion between scents. Therefore, the particular selection and grouping of odor labels 34 decreases the occurrence of false-positive test results and increases the reliability of the olfactory test as an indicator of olfactory dysfunction. [0017] A rectangle with rounded corners, the same dimensions as odor strip 36, 4.0 cm. in length by 1.25 cm in width, illustrating where odor strip 36 should be attached, is printed on the right bottom corner of odor page 28. The printed rectangle allows for consistent uniform attachment of odor strip 36 to odor page 28 during assembly of test booklet 12. Each odor page 28 has a different odor strip 36 attached in the printed rectangle to odor page 28 via adhesive.
[0018] FIG. 5 is a three-dimensional view of odor page 28. Odor strip 36 is an odor-containing source. Odor strip 36 contains a plurality of rupturable microcapsules . A distinct scent is located within the microcapsules which is emitted when the microcapsules rupture or burst, as a result of scratching the surface of odor strip 36 with pencil 18. Other objects can be used to scratch the surface of odor strip J6 so as to accomplish rupture. As the microcapsules are ruptured, a burst of fragrance of the distinct scent contained within the .microcapsules is given off. Pencil 1.8 is provided in the te.st kit for the examinee to use to scratch the surface of odor strip 36 and rupture the microcapsules. [0019] Odor strip 36 is a rectangular strip of paper with rounded corners measuring 4.0 cm in length by 1.25 cm in width. Each odor page 28 contains one odor strip 36 each containing one of the following odors: cinnamon, turpentine, lemon, smoke, chocolate, rose, paint thinner, banana, pineapple, gasoline, soap, and onion. A particular odor strip 36 is chosen from the grouping of odor labels 34 to provide a diverse, cross-cultural olfactory test. Odor- strips 36 comprise six food-related odor strips and six nonfood-related odor strips. Odor -strips 36 are also chosen based on commercial availability. [0020] Each odor strip 36 has a unique distinguishing visual feature. Each odor strip 36 is a different color. The following color corresponds to each odor strip 36: (1) for cinnamon, brown; (2) for turpentine, light yellow; (3) for lemon, light green; (4) for smoke, peach; (5) for chocolate, light pink; (6) for rose, white; (7) for paint thinner, gray; (8) for banana, dark pink; (9) for pineapple, orange; (10) for gasoline, green; (11) for soap, dark yellow; and (12) for onion, blue. Different colored odor strips are used for post-assembly verification and quality assurance. By color-coding the odor strips, each odor page 28 can' be checked to ensure that the correct odor strip 36 was attached to its respective corresponding odor number 32. Other colors can be used to distinguish odor strips 36. Additionally, other coding schemes using distinguishing visual features can be employed.
[0021] FIG. 6A is inside back cover 38 of- test booklet 12 containing answer key 40. Answer key cover 43 is paper, 16.0 cm in length by 7.0 cm in width attached 1.0 cm below the top of inside back cover 38 via adhesive. The paper is dense to prevent the text of answer key 40 from being visible through answer key cover 43. The bottom of inside back cover 38 and bottom of- answer key cover 43 are attached with a breakable seal. Answer key cover 43 hides answer key 40 from view until the seal is .broken and answer key cover 43 is lifted to view answer key 40. [0022] Inside back cover 38 is labeled "answer key." Underneath the label is written "important: .do not read this page until you have completed the test." The -label and text are located in the top 1.0 cm of inside back cover 38, so as to be visible with answer key cover 43 attached. The odor numbers and the corresponding answers, correctly identifying each odor-containing source, are listed vertically in two columns, six answers per column as follows: in the first, left column: Odor #1 = cinnamon; Odor #2 = turpentine; Odor #3 = lemon; Odor #4 = smoke; Odor #5 = chocolate; Odor #6 = rose; in the second, right column: Odor #7 = paint thinner; Odor #8 = banana; Odor #9' = pineapple; Odor #10 = gasoline; Odor #11 = soap; and Odor #12 = onion. "Total number incorrect" is written on the bottom of FIG. 6A. Blank box 42, 3.0 cm in length by 1.0 cm in width, is an area to the right of the phrase for examinee to record the total number of odor-containing sources incorrectly identified.
[0023] FIG. 6B illustrates top half 46 of back side of last odor page 44. Top half 46 of FIG. 6B is labeled "scoring the test" and gives instructions for self- scoring the olfactory test from answer key 40. Self- scoring reveals the number of odor-containing sources examinee incorrectly identified. The total number of incorrect identifications is used in self-screening a positive or negative result of the olfactory test. [0024] The step-by-step instructions for self-scoring are: (1) after. sniffing all 12- odor strips '36 and circling one answer per page,, remove answer key cover 43 and look at answer key 40, FIG. 6A, to the right of this page; (2) starting with Odor #1, compare the correct answer found on answer key 40 with the one you circled; if the two do not match, place a line through Odor #1 on answer key 40; (3) a scoring example if answer key and the odor label choice do not match is given in information booklet 14; (4) if you chose correctly and the two match, go to Odor #2; continue until you have viewed and scored each odor for correctness (Odor #1 through Odor #12); (5) after comparing each of your circled answers to answer key 40, total the number of odors you have placed a line through (incorrect answers) ; and (6) write that number in blank box 42 provided on answer key 40. [0025] FIG. 6B also illustrates bottom half 48 of back side of last odor page 44. Bottom half 48 provides instructions for self-screening to determine a positive or negative result of the olfactory test based on the total number of incorrect answers self-scored from answer key 40. Bottom half 48 is labeled "reading the results." Below the label are the self-screening instructions:
"after carefully totaling the number of incorrect answers and writing that number in the total number incorrect' box, you can read your results. If you have 4 or more incorrect items you should consult your physician. If you' do not have 4 or more incorrect items and are experiencing symptoms of Alzheimer's disease (see signs and symptoms of section found in the information booklet), contact your physician. Early Alert is not a diagnostic test nor a conclusive test for Alzheimer's disease. Early Alert has been designed to assist in early detection of possible Alzheimer's disease by testing your sense of smell- Further testing is recommended. Poor performance on this screening test does not necessarily mean you have Alzheimer's disease. See information booklet."
[0026] FIG. 6C is information booklet 14.. Information booklet 14 comprises one blue sheet- of paper 28.0 cm in length by 16.75 cm in width. The paper is folded in half lengthwise to create a four page booklet that is 14.0 cm in length by 16.75 cm in width. On' the first page, information booklet 14 is titled "Information Booklet" and subtitled "Early Alert Home Screening Test for Alzheimer's Disease." [0027] The first page contains an initial instruction under the subtitle to "please read all of the instructions completely before performing the screening test. The directions will help .you correctly perform the test and read the results." A telephone help line number and a website address are also listed. Following the initial instruction is text labeled "information about the test." The text states that "smell loss is among the first signs of Alzheimer's disease (AD). The Early Alert Alzheimer's Home Screening Test is a smell test that allows an individual to determine if a loss of olfactory function (the ability to smell) is present. Although not all older persons with smell loss have AD, such loss, alone or in combination with memory problems and/or certain genetic markers, is among the best predictors or indicators of AD. Early Alert has been designed to assist in early detection of possible AD by determining if you have a degraded sense of smell.- Failing the test does not .necessarily mean you have AD. If you fail the screening test you should consult your physician. If you do not fail the test and are experiencing symptoms of AD (See Signs and. Symptoms ) , consult your physician." [0028] Following the initial instruction are bulleted statements labeled "contents of the home screening test." The text lists the. contents of the test kit as described in FIG. 1. Next, -bulleted statements labeled "test booklet storage and handling" follow. The bulleted statements are the same as the bulleted points described oh outside back cover 22. Additional bulleted statements labeled "test limitations" subsequently follow.' The statements are: (1) the Early Alert screening test works only if the directions are followed precisely as noted; (2) the Early Alert screening test kit can only be used one time and prior to the expiration date; (3) decreased olfactory function (sense of smell) is not the only indicator of potential AD; and (4) decreased olfactory function (sense of smell) can be found in older individuals without AD. Finally, at the bottom of the first page is text labeled "test validity and reliability." The text states that "this test is the most widely employed means of quantitatively assessing the sense of smell. Numerous published scientific and medical studies have employed this exact format and a number have found smell loss to be among the first, if no the first signs of AD. In some cases these studies demonstrated that such loss more or less predicts who, among at-risk individuals, will likely develop AD eventually . " [0029] The second page, located" on the reverse of the first page, is titled "directions" and subtitled "how to. take the test." The second page is divided into two sections. The first section is labeled "cautions," and comprises bulleted statements. The statements are: (1) do not attempt the screening test- if you. currently have nasal congestion or long-lasting smell loss due to other known causes; (2) do not scratch the odor strip until you are ready to sniff the odor; (3) poor performance on the screening test does hot necessarily mean you have
Alzheimer's disease; (4) read all of the contents of this information booklet before you begin the screening test; (5) do not turn to the answer key or look at the answer key before completing the test. [0030] The second section is labeled "directions" and contains sequentially numbered instructions and illustrations. Instruction number one is "open the screening test booklet to the first page, which is titled Odor #1." The next two instructions are the same as the first two instruction's 30 on odor page 28, with the same illustrations .
[0031] Instruction number four is "look at the choices provided on the page located above the odor strip. If you are not sure or no smell is present, pick the one that seems closest. Circle the best answer. You must circle one answer." Centered under instruction number four is the phrase "example of answer choice." Centered below the phrase is a vertical list, one choice per horizontal line, of four odor labels: fruit, cinnamon, coconut, and woody. Fruit is circled. Instruction number five is "turn the page of the test booklet to the second page which contains Odor #2. Repeat Step 2 through Step 4 above." Instruction number six is "continue this process until all 12 odor strips have been sniffed and an answer has been circled for each odor." [0032] The third page labeled "directions" comprises three sections. The first section is labeled "how to score the test." The text in the first section is the same as top half 46 of back side of last odor page 44. With the text is an illustration of how to self-score each answer. The example shows "Odor #1, oody" with a line through, i.e. "Odor #1 Woody-.--" Additionally, an illustration of blank box 42, 1.75 cm in length by 0.4 cm in width, is given to the right of the phrase "total number incorrect."
[0033] The second section is labeled "reading the results." The text in the second section is the same text found in bottom half 48 of back side of last odor page 44. The third section is .labeled "frequently asked questions." Seven questions, each question labeled on the left with a "Q, " are paired with an answer, labeled on he left with an "A." The seven questions and paired answers are: (1) Why do I want to take a home screening test for Alzheimer's? Early diagnosis is very important. Increasing you awareness of possible Alzheimer' s disease can help you receive further testing which may lead to potential diagnosis. As a result, you can increase your chance of -benefiting from current treatments, improve your quality of life, resolve anxiety, and plan for the future; (2) If I have trouble completing and scoring the test, what should I do? Call the telephone help line number or visit the website address given; (3) What if I have a stuffy nose .from a cold and take the test? Taking the test while having nasal congestion is not recommended. Wait until you are healthy and free of symptoms; (4) What should I do if I do not smell anything at all on the odor strip? If you are not sure or no smell is present,, pick the one that seems closest; (5) If I have 4 or more odors incorrect do I have Alzheimer' s disease? No! Failing this screening test does not mean you have Alzheimer's disease. If you had 4 or more odors incorrect you should consult your physician; (6) If I have less than 4 odors incorrect does that mean I do not have Alzheimer's disease? No, factors other than smell can be used in the Alzheimer's disease diagnosis process. -If you have signs or symptoms of consult your physician. (see signs and symptoms); (7) Can I give my test to someone else? No! The test is a single use test. [0034] The fourth page is untitled and contains three sections. The first section is labeled "Alzheimer's Disease - more information'-." The first section provides general information on Alzheimer's Disease and lists websites with more information on Alzheimer's Disease. The second section is labeled "signs and symptoms." The section begins with "the following information is- taken from a widely distributed list of warning signs for Alzheimer's disease." The statement is then followed eight items arranged in a two column vertical unnumbered list, with four items in each column. The items in the first, left column are: (1) misplacing things; (2) word finding problems; (3) poor or decreased judgment; and (4) recent memory loss. The items in the second, right column are: (1) difficulty performing familiar tasks; (2) disorientation to time and place; (3) loss of interest; and (4) changes in mood or behavior. The third section is labeled "medical and scientific references." The third section lists journal articles on Alzheimer's Disease and olfactory dysfunction.
[0035] FIG. 6D is physician's information card 16 labeled "physician's information." Physician's information card 16 comprises one sheet of paper, 17.0 cm in length by 8.5 cm in width. Physician's information card 16 has text printed on both the front side of the card and the back side of the card. Immediately below the title on the front side of .th physician's information card are the statements: "we ■' strongly recommend that you bring this card with' you when conferring with your physician. We also suggest that you bring the screening. test and information booklet." Physician information card 16 is then formatted as a letter to the physician, beginning, "dear physician." The text of the letter explains the olfactory test methodology and indications of a positive .result. [0036] FIG. 7A is a flowchart of the preparation for self-administration the olfactory test. An examinee opens in step 60 the sealed paper box 10 and removes in step 60 the contents: test booklet 12, information booklet 14, physician information card 16, and pencil 18. In step 62, examinee reads information booklet 14. [0037] In step 64, if examinee has long lasting smell loss due to other known causes, examinee is instructed in step 76 not to take the olfactory test. If not, but in step 66 examinee currently has nasal congestion, examinee is instructed in step 78 not to take the olfactory test and, in step 86, to store the test until nasal congestion clears. In steps 80 through 84, examinee stores the test in a dry place at a temperature below 30°C (86°F), but does not refrigerate the test. If examinee fails to comply with the storage instructions, then step 76 instructs examinee not to take the olfactory test and to discard the test.
[0038] If examinee has no nasal congestion in step 66 or if nasal congestion has cleared in step 86, but the expiration date in step 68 has passed, examinee is instructed in step 76 not to take the olfactory test and to discard the test. If the expiration date in step 68 has not passed, but in step 70 if any odor strip 36 has come into contact with any liquid, or in step 72 if any odor strip 36 has been scratched, step 76 instructs examinee not to take the olfactory test and to discard the test. If not, then in step 74, examinee may begin the olfactory test.
[0039] FIG. 7B is a flowchart of the' self- administration method of the olfactory test. In step 88, examinee breaks the seal of test booklet 12 and in step 90 opens test booklet 12 to inside front cover 22. In step 92, examinee reads the points labeled "important" on inside front cover 22. If examinee has looked at answer key 40 in step 94, then in step 96, examinee is instructed not to take the olfactory test. In step -94, if examinee has not looked at answer key 40, then in step 98, examinee looks at first odor page 28. [0040] In step 100, examinee uses the sharp end of pencil 18 to scratch odor strip 36 several times in a . zig-zag fashion, releasing the odor from the odor- containing area. In step 102, examinee places odor strip 36 directly under both nostrils and in step 104, sniffs odor strip 36. In step 106, examinee looks at odor labels 34 and in step 108, uses pencil 18 to circle the odor label that odor strip 36 smells most like. In step 110, if odor page 28 is not odor #12, then in step 112, examinee turns to the next odor page 28 and repeats steps 100 through 110. When in step 110 the odor number is twelve, then examinee begins to score the test in step 114.
[0041] FIG. 7C is a flowchart of the olfactory test's self-scoring method to determine a number of incorrect answers that indicate a positive result. In step 114, after examinee circles an odor label for Odor #12, examinee turns in step 116 to back side of last page 44, and in .step 118 reads the "scoring the -test" section on top half 46. In step 120, examinee looks at- answer key 40 on inside back cover 38. In step 122, examinee looks at the answer for odor #1. In step 124, examinee then looks at the circled odor label for odor #1. In step 126, if the circled label for odor #1 matches the answer for odor #1 in answer key 40, examinee looks at .the next odor number and repeats steps 124 through 132. If in step 126, the answer for odor #1 does not match the circled odor label for odor #1, then examinee, in step 128, uses pencil 18 to draw a line through the answer in answer key 40, and then repeats steps 124 through 132. [0042] When in step 132, the odor number is twelve, examinee counts in step 134 the answers in answer key 40 with a line through (the incorrect answers) . In step 136, examinee records the total number of incorrect answers in blank box 42 provided next to the phrase "total incorrect number." In step 138, examinee then self-screens the score.
[0043] FIG. 7D is a flowchart of the olfactory test's self-screening method to determine a positive or negative result from the total number of incorrect answers self- scored from answer key 40. In step 140, examinee reads bottom half 48 of back side of last odor page 44,
"reading the results." If examinee's total incorrect number is four or more, examinee is instructed to consult a physician in step 150. If the examinee needs to consult a physician in step 150, then examinee is further instructed in step .152 to take physician's information' card 16 to the physician.
[0044] Recording a score of four or more incorrect answers on a twelve odor strip test reveals a statistically significant probability of olfactory dysfunction that is an early detectable symptom of neurological disease, in particular, of Alzheimer's Disease (AD) . Studies have shown that incorrectly identifying at least one-third of a total number of odor strips indicates olfactory dysfunction attributable to AD. For example, studies report that one hundred percent of patients diagnosed- with AD incorrectly identified one- third or more of a total number of odor strips (in this case, one or more odor strips in a three odor strip test) ; whereas only twenty percent of patients not currently diagnosed with AD incorrectly identified one out of three odor strips. Additionally, 'in the same studies, none of the non-AD patients incorrectly identified more than one-third of the odor' strips; whereas between seventy-five to ninety-five percent of the AD patients incorrectly identified more' than one- third of the odor strips.
[0045] In a twelve-item olfactory test, another study reports that ninety-nine percent of individuals age 45 to age 49 recording a score of four of more . incorrect answers suffer from olfactory dysfunction. Additionally, at least ninety percent of women and seventy-two percent of men age 65 to age 69 correctly identifying eight or less of the twelve odor strips (scoring four incorrect answers) suffer from olfactory dysfunction.
[0046] In step 142, if examinee's total incorrect number is less than four, then examinee is instructed in step 144 to read the section in information booklet 14 labeled "signs and symptoms." In step 146, if examinee is experiencing any of the listed signs or symptoms of Alzheimer's Disease, examinee is instructed in step 150 to consult a physician. If the examinee needs to consult a physician in step 150, then examinee i's further instructed in step 152 to take physician's information card 16 to the physician. If examinee's total number -incorrect is less than four' in step 142 and examinee is not experiencing any listed signs or symptoms of Alzheimer's Disease in step 146, examinee in step 148 needs to take no further action.
[0047] ' The self-screening olfactory test kit eliminates the need for healthcare professional involvement for initial screening of neurological disease. The olfactory test kit requires only a small time commitment since an individual can self-administer and self-score the olfactory test in about, five minutes. Additionally, ther cost of the olfactory test kit for individual desiring initial screening of neurological disease is minimal compared with an office visit to a healthcare professional.
[0048] The olfactory test kit provides individuals with a simple self-screening method to determine a positive result of the olfactory test upon incorrectly identifying one-third or more of the total number of odor-containing areas. A positive result of the. olfactory test is an indication of olfactory dysfunction which is not a diagnosis of neurological disease rather an indication that an individual should take further action regarding possible neurological disease, such as consulting a physician. Individuals not only self- administer the olfactory test in a private, in-home setting, but also self-score the olfactory test to determine themselves if the results indicate that further action is required. The olfactory test kit is a quick, inexpensive, private, self-screening, diagnostic tool that does not incur anxiety associated with healthcare professional involvement. As a result, the olfactory test kit will avail more individuals of the benefits of early screening of possible neurological disease. '[0049] Although the present invention has been described with respect to preferred embodiments, any person skilled in the art will recognize that changes may be that changes be made in form and detail, and equivalents may be substituted for -elements of the invention without departing from the spirit and scope of the invention'. Many modifications may be made to adapt to a particular situation or material to the teaching of .the invention without departing from the essential scope of the invention. Therefore, it is intended that the invention not be limited to the particular embodiments disclosed for carrying out this invention, but that the invention will include all embodiments falling within the scope of the appended claims.

Claims

What is claimed is:
1. An olfactory test' for self-screening of a neurological disease, comprising: a booklet including a plurality of pages; an odor-containing source on one page of the plurality of pages; a plurality of labels providing choices of possible identity of the odor-containing source; an answer key on one page of the plurality of pages correctly identifying the odor-containing source; and an instruction on one page of the plurality of pages for self-scoring the olfactory test from the answer key to determine a ' number of incorrect answers that indicate a positive result of the olfactory test.
2. The olfactory test of claim 1, further including a first instruction to take further action regarding the neurological disease upon self-scoring the positive result of the olfactory test.
3. The olfactory test of claim 1, wherein the instruction includes: a first instruction to compare a selected label from the plurality of labels to the answer key; a second instruction to indicate an incorrect answer; and a third instruction to ascertain the number of incorrect answers.
4. The ol'factory test of claim 1, further including a first instruction to take further action upon a negative result of the olfactory test yet experiencing symptoms of the neurological disease.
5. The olfactory test of claim 1, wherein the answer key includes a correct answer' for each odor-containing source such that incorrect answers can be indicated.
6. The olfactory test of claim 1, further including an area to record the number of incorrect answers.
7. The olfactory test of claim 1, further including a cover over the answer key.
8. The olfactory test' of claim 1, wherein the plurality of labels selected for the odor-containing source are distinctly different from one' another.
9. The olfactory test of claim 1, wherein the odor- containing source has a unique distinguishing visual feature.
10. The olfactory test of claim 1, wherein the neurological disease is Alzheimer's disease.
11. An olfactory test booklet, comprising: a first page including an instruction for use of an olfactory test; a plurality of second pages each including an odor- containing source; a plurality of labels providing choices of possible identity for each odor-containing source; a third page including an answer key correctly identifying each odor-containing source; and a fourth page including an instruction for self- scoring the' olfactory test from the answer key to determine a. number of incorrect answers that indicate a positive result of the olfactory test.
12. The olfactory test booklet of claim 11, further including: a first page including,
(a) a first instruction to compare a selected label from the plurality of labels to the answer key; (b) a second instruction to indicate an incorrect answer; and
(c) a third instruction to ascertain the number of incorrect answers.
13. The olfactory test booklet of claim 11, wherein the answer key includes a correct answer' for each odor- containing source such that incorrect answers can be indicated;
14. The olfactory test booklet of claim 11, further including a first page with an area to record the number of incorrect answers.
15. The olfactory test booklet of claim 11, further including a cover over the answer key.
16. The olfactory test booklet of claim 11, wherein the plurality of labels selected for the odor-containing source are distinctly different from one another.
17. The olfactory test booklet of claim 11, wherein four labels are selected for each odor-containing source.
18.- The olfactory test booklet of claim 11, wherein the odor-containing source has a unique distinguishing visual feature .
19. A method of self-screening of a neurological disease, -comprising: providing an odor-containing source capable of releasing an odor; providing a plurality of labels as choices of possible identity of the odor-containing source; providing an answer key which correctly identifies the odor-containing source to compare against a selected label from the plurality of labels; and' providing an instruction for self-scoring using the answer key to determine a number of incorrectly selected labels that indicate a positive result.
20. The method of self-screening in claim 19, further including providing a first instruction to take further action regarding the, neurological disease upon the positive result.
21. The method of self-screening in claim 19, further including providing a first instruction to take further action upon a negative result yet experiencing symptoms of the neurological disease. '
22. The method of self-screening in claim 19, further including providing a cover over the answer key.
23. The method of self-screening in claim 19, further including selecting a plurality of labels for the odor- containing source that are distinctly different from one another.
24. A method of manufacturing an olfactory test booklet, comprising: assembling the olfactory test booklet including a plurality of pages; printing a first page including an- instruction for use of an olfactory test; . printing a second page and applying an odor- containing source to the second page; printing a plurality of labels providing choices of possible identity for each odor-containing source; printing a third page including an answer key correctly identifying each odor-containing source; and printing a fourth page including an instruction for self-scoring the olfactory test from the answer key to determine a number of incorrect answers that indicate a positive result of the olfactory test.
25. The method of manufacturing in claim 24, further including printing a plurality of second pages and applying one odor-containing source to each page of the plurality of second pages.
26. The method of manufacturing, in claim 24, further - including assembling a cover over the answer key .
27. The method of manufacturing in claim 24, further including printing a first page including an area to record the number of incorrect answers.
28. An olfactory test kit for self-screening of a neurological disease, comprising: an odor-containing source capable of releasing an odor; an area for recording possible identity of the odor; an answer key correctly identifying the odor; and an instruction for self-scoring the olfactory test from the answer key to determine a number of incorrect answers that indicate a positive result.
29. The olfactory test kit in claim 28, wherein the area for recording the possible identity of the odor includes a plurality of labels providing choices of the possible identity of the odor.
30. The olfactory test kit in claim 28, wherein the olfactory test is a booklet.
31. The olfactory test kit in claim 28, further including a first sheet with an instruction for use of the olfactory test.
32. The olfactory test kit in claim 28, further including a first sheet with an instruction about the olfactory test for a healthcare professional.
33. The olfactory test kit in claim 28, further including an instrument for releasing the odor from the odor-containing source.
34. The olfactory test kit in claim 28, further including a cover over the answer key. ,
35. The olfactory test kit in claim 28, further including an area to record the number of incorrect answers.
36. The olfactory test kit in claim 28, further including an instrument for recording the possible identity of the odor-containing source.
37. The olfactory test kit in claim 28, further including an instrument "for self-scoring the olfactory test.
37
PCT/US2002/039800 2001-12-13 2002-12-12 Self-scoring method and apparatus for early self-screening of neurological disease WO2003051177A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002353133A AU2002353133A1 (en) 2001-12-13 2002-12-12 Self-scoring method and apparatus for early self-screening of neurological disease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/015,442 US20030113701A1 (en) 2001-12-13 2001-12-13 Self-scoring method and apparatus for early self-screening of neurological disease
US10/015,442 2001-12-13

Publications (3)

Publication Number Publication Date
WO2003051177A2 true WO2003051177A2 (en) 2003-06-26
WO2003051177A3 WO2003051177A3 (en) 2003-09-25
WO2003051177B1 WO2003051177B1 (en) 2003-10-30

Family

ID=21771428

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/039800 WO2003051177A2 (en) 2001-12-13 2002-12-12 Self-scoring method and apparatus for early self-screening of neurological disease

Country Status (3)

Country Link
US (2) US20030113701A1 (en)
AU (1) AU2002353133A1 (en)
WO (1) WO2003051177A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150177202A1 (en) * 2013-12-20 2015-06-25 University Of Tennessee Research Foundation Odor threshold test

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7835922B2 (en) * 2004-07-08 2010-11-16 Astrazeneca Ab Diagnostic system and method
US7422435B2 (en) * 2004-12-02 2008-09-09 Holt Christopher L Task-oriented book with functional features for facilitating experiential learning
US20060183099A1 (en) * 2005-02-14 2006-08-17 Feely Richard A Education and test preparation system, method and computer program product
WO2006135368A1 (en) * 2005-06-10 2006-12-21 The Trustrees Of Columbia University In The City Of New York Olfactory identification tests for cognitive diseases and disorders
US20070248542A1 (en) * 2006-04-24 2007-10-25 Bodybio, Inc. Devices and methods for individualized detection of nutrient imbalance via olfactory system
PL2194781T5 (en) * 2007-10-04 2021-11-15 Société des Produits Nestlé S.A. Compositions and methods for enhancing cognitive function
FR2923064B1 (en) * 2007-10-31 2010-01-01 Hill Rom Sas DEVICE FOR STIMULATING THE MEMORY OF A PATIENT.
US20090287064A1 (en) * 2008-05-15 2009-11-19 Medical Interactive Education, Llc Computer implemented cognitive self test
EP2174585A1 (en) * 2008-09-29 2010-04-14 Carlo Maremmani Olfactory identification test kit for determining neurological disorders
US8043214B2 (en) * 2009-03-05 2011-10-25 Puthalath Koroth Raghuprasad Neuro-aid
JP5351942B2 (en) * 2011-09-07 2013-11-27 シャープ株式会社 Dementia care support system
US20130081961A1 (en) * 2011-10-03 2013-04-04 Ferdinand Konan Kouadio Fragrance testing strips combined with a nose clearing devise
US20150216414A1 (en) * 2012-09-12 2015-08-06 The Schepens Eye Research Institute, Inc. Measuring Information Acquisition Using Free Recall
WO2014113645A1 (en) * 2013-01-18 2014-07-24 University Of Florida Research Foundation, Inc. Methods and tests for degenerative disorders of the central nervous system
US20140349260A1 (en) * 2013-05-24 2014-11-27 Deborah L. HILL Promises tracking device and method thereof for enhancement of behavior control
US9801581B2 (en) 2013-10-22 2017-10-31 Inspired Technologies, Inc. Devices, systems and methods for detecting a bilateral differential in olfactory threshold for pure odorants
US9717454B2 (en) 2014-07-11 2017-08-01 Inspired Technologies, Inc. Method of ruling out Alzheimer's disease
US20160220165A1 (en) * 2015-06-30 2016-08-04 Safa Taherkhani Detecting olfactory malingering
EP3245944A1 (en) * 2016-05-20 2017-11-22 Institut Pasteur Olfactory means for the diagnosis of neurological complications of nervous system infection
US20170345334A1 (en) * 2016-05-25 2017-11-30 Michael DIGIORGIO Online Training with Live Instruction
JP6875885B2 (en) * 2017-03-01 2021-05-26 小林製薬株式会社 Smell test kit and scent applicator
TWI701015B (en) * 2019-06-27 2020-08-11 牛耳國際生技有限公司 Olfactory testing device and olfactory testing method
US20230248297A1 (en) * 2020-04-24 2023-08-10 The General Hospital Corporation Systems and methods for administering a smell test for sars coronaviruses and covid-19
USD972421S1 (en) 2020-07-17 2022-12-13 Derek Kalev Toomre Multi-odorant testing device
USD1010664S1 (en) 2020-09-12 2024-01-09 u-Smell-it LLC Display screen with a graphical user interface
US11337640B2 (en) * 2020-10-16 2022-05-24 Monell Chemical Senses Center Multifunctional smell test

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989000398A1 (en) * 1987-07-17 1989-01-26 The Regents Of The University Of California Diagnostic test for alzheimer's disease
US5447439A (en) * 1993-07-09 1995-09-05 Nathanson; Ted Interactive story book using stickers and a method of teaching
US20020139170A1 (en) * 2001-04-02 2002-10-03 Doty Richard L. Smell test device

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2977689A (en) * 1958-10-30 1961-04-04 Gerhard T Rugland Multiple choice response device
US3359656A (en) * 1966-01-13 1967-12-26 Courier Citizen Company Answer sheet indicating correctness and recording errors
US3570139A (en) * 1969-08-18 1971-03-16 Janice S Ladd Teaching apparatus
US4687203A (en) * 1986-05-15 1987-08-18 Donald Spector Scratch and smell game
US5230629A (en) * 1991-03-01 1993-07-27 Albert Einstein College Of Medicine Of Yeshiva University Device and method for assessing cognitive speed
US5380765A (en) 1992-09-30 1995-01-10 Hirsch; Alan R. Chemosensory olfactory assay for psychiatric disorders
US6325475B1 (en) 1996-09-06 2001-12-04 Microfab Technologies Inc. Devices for presenting airborne materials to the nose
US6152887A (en) * 1998-02-27 2000-11-28 Blume; Richard Stephen Method and test kit for oral sampling and diagnosis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989000398A1 (en) * 1987-07-17 1989-01-26 The Regents Of The University Of California Diagnostic test for alzheimer's disease
US5447439A (en) * 1993-07-09 1995-09-05 Nathanson; Ted Interactive story book using stickers and a method of teaching
US20020139170A1 (en) * 2001-04-02 2002-10-03 Doty Richard L. Smell test device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150177202A1 (en) * 2013-12-20 2015-06-25 University Of Tennessee Research Foundation Odor threshold test

Also Published As

Publication number Publication date
US6957038B1 (en) 2005-10-18
AU2002353133A1 (en) 2003-06-30
WO2003051177B1 (en) 2003-10-30
WO2003051177A3 (en) 2003-09-25
US20030113701A1 (en) 2003-06-19
AU2002353133A8 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
US6957038B1 (en) Self-scoring method and apparatus for early self-screening of neurological disease
Franzen et al. The detection of malingering in neuropsychological assessment
McCarthy Situated clinical reasoning: Distinguishing acute confusion from dementia in hospitalized older adults
US20070077204A1 (en) Olfactory identification tests for cognitive diseases and disorders
Pryor et al. Laxative abuse among women with eating disorders: an indication of psychopathology?
Tidwell et al. Youth at risk: In search of a definition
Pentzek et al. Odor identification in Alzheimer’s disease and depression
Duclos et al. Impairment of social cognition in neurological diseases
WO2006135368A1 (en) Olfactory identification tests for cognitive diseases and disorders
Gamino et al. Who needs grief counseling? A report from the Scott & White Grief Study
Broome et al. Evaluating the drug-abusing probationer: Clinical interview versus self-administered assessment
Sala et al. Slowly progressive impairment of spatial exploration and visual perception
Glass et al. Cognitive impairment screening in second offense DUI programs
Clarizio et al. A survey of school psychologists' perspectives and practices with childhood depression
Kay et al. Preliminary evaluation of a scale to assess cognitive function in adults with Down's syndrome: the Prudhoe Cognitive Function Test
JP2005013713A (en) Measurement of attention function, and method and apparatus for learning attention function
Brigham et al. Assessment of EBD
Horton Jr The Halstead-Reitan neuropsychological test battery: past, present, and future
Goldstein et al. Alternative methods, challenging issues, and best practices in the assessment of autism spectrum disorders
Hutchinson The Luria-Nebraska Neuropsychological Battery controversy: A reply to Spiers.
Glasgow et al. What do expert witnesses in child sexual abuse think they are doing?—‘Diagnosis’, and the sexually accurate doll ‘test’as professional myths
Lang Subtyping closed head injury patients using the Dean-Woodcock Neuropsychological Assessment System
Cook A rare and challenging differential diagnosis: Prosopagnosia and reduced empathy in right-variant semantic dementia–where ‘understanding does not map onto reality’
KR20220051139A (en) Composition for diagnosing degenerative brain disease containing 2-phenylethyl alcohol and method for diagnosing degenerative brain disease using the same
Faletar How much do library students know about dementia? Findings from a quantitative study using Alzheimer’s Disease Knowledge Scale

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
B Later publication of amended claims

Free format text: 20030729

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP